Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Science & Technology International (STI) was a research and development company that specialized in advanced imaging and sensing technologies, with a significant focus on medical diagnostics. The company developed a proprietary hyperspectral imaging platform designed to improve the early detection of various cancers, most notably cervical and skin cancers. Its flagship medical product, the Spectra system, utilized automated multi-spectral imaging to provide real-time, non-invasive diagnostic information. STI's medical division, often referred to as STI Medical Systems, was a pioneer in applying defense-grade remote sensing technology to clinical healthcare challenges. The company was eventually acquired by Northrop Grumman, which integrated its sensing capabilities into its broader defense and technology portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Science & Technology International.